Sort   by:  
 Page size 
UnknownRandomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.
Not available
S-EPMC4966514 | biostudies-literature
UnknownRandomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer.
Not available
S-EPMC4881365 | biostudies-literature
UnknownHLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering.
Not available
S-EPMC2668443 | biostudies-literature
UnknownSUsPECT: a pipeline for variant effect prediction based on custom long-read transcriptomes for improved clinical variant annotation.
Not available
S-EPMC10245480 | biostudies-literature
UnknownTransmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.
Not available
S-EPMC2373834 | biostudies-literature
UnknownA perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection.
Not available
S-EPMC6358518 | biostudies-literature
Genomicsena-DATASET-JHU-29-06-2015-20:17:30:536-212 - samples
Clinical Implications of Genomic Alterations in the Tumour and Circulation of Pancreatic Cancer Patients
EGAD00001001421 | EGA
GenomicsClinical Implications of Genomic Alterations in the Tumor and Circulation of Pancreatic Cancer Patients
Pancreatic adenocarcinoma has the worst mortality of any solid cancer. To evaluate the clinical implications of genomic alterations in this tumor type, we performed whole-exome analyses of 24 tumors, targeted genomic analyses of 77 tumors, and used non-invasive approaches to examine tumor-specific ...
EGAS00001001257 | EGA
GenomicsPancreatic Adenocarcinoma Data Access Committee
Data Access Committee EGAC00001000358
EGAC00001000358 | EGA
Genomicsena-DATASET-LUDJHU-29-01-2018-17:38:21:660-204 - samples
Sequencing data from 1,005 cancer patients and 812 healthy controls. All samples prepared using Safe-SeqS technology and sequenced on an Illumina MiSeq and/or HiSeq instrument. Paired FASTQ files for correspond to read 1 and the index read present (R and I respectively).
EGAD00001003931 | EGA
Sort   by:  
 Page size